Source: Clinics. Unidade: FMRP
Subjects: COVID-19, OBESIDADE, CORONAVIRUS, FATORES DE RISCO, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WATANABE, Ligia Moriguchi et al. The influence of bitter-taste receptor (TAS2R) expression in pharmacological response to Chloroquine in obese patients with COVID-19. [Editorial]. Clinics. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.6061/clinics/2020/e2181. Acesso em: 29 maio 2024. , 2020APA
Watanabe, L. M., Pires, I. F., Noronha, N. Y., Pinhel, M. A. de S., & Nonino, C. B. (2020). The influence of bitter-taste receptor (TAS2R) expression in pharmacological response to Chloroquine in obese patients with COVID-19. [Editorial]. Clinics. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.6061/clinics/2020/e2181NLM
Watanabe LM, Pires IF, Noronha NY, Pinhel MA de S, Nonino CB. The influence of bitter-taste receptor (TAS2R) expression in pharmacological response to Chloroquine in obese patients with COVID-19. [Editorial] [Internet]. Clinics. 2020 ; 75 1-3.[citado 2024 maio 29 ] Available from: https://doi.org/10.6061/clinics/2020/e2181Vancouver
Watanabe LM, Pires IF, Noronha NY, Pinhel MA de S, Nonino CB. The influence of bitter-taste receptor (TAS2R) expression in pharmacological response to Chloroquine in obese patients with COVID-19. [Editorial] [Internet]. Clinics. 2020 ; 75 1-3.[citado 2024 maio 29 ] Available from: https://doi.org/10.6061/clinics/2020/e2181